Delhi High Court directs Central government to release over Rs 14 crore to Panacea Biotec for manufacturing Sputnik-V

As an interim arrangement, the Court also directed Panacea Biotec to deposit 20 percent of the sale proceeds with the court's registry.
Delhi High Court directs Central government to release over Rs 14 crore to Panacea Biotec for manufacturing Sputnik-V
Sputnik vaccine, Delhi high court

The Delhi High Court on Friday directed the Central government to release Rs 14 crore along with interest to vaccine maker, Panacea Biotec for manufacturing COVID-19 vaccine, Sputnik-V subject to the company obtaining permission to manufacture it in India.

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In

Related Stories

No stories found.